- Home
- WELL vs GSK Comparison
WELL vs GSK Comparison
Compare WELL & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WELL
- GSK
- Stock Information
- Founded
- WELL 1970
- GSK 1715
- Country
- WELL United States
- GSK United Kingdom
- Employees
- WELL N/A
- GSK N/A
- Industry
- WELL Real Estate Investment Trusts
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- WELL Real Estate
- GSK Health Care
- Exchange
- WELL Nasdaq
- GSK Nasdaq
- Market Cap
- WELL 85.2B
- GSK 74.6B
- IPO Year
- WELL N/A
- GSK N/A
- Fundamental
- Price
- WELL $148.64
- GSK $36.64
- Analyst Decision
- WELL Buy
- GSK Hold
- Analyst Count
- WELL 10
- GSK 4
- Target Price
- WELL $143.45
- GSK $47.00
- AVG Volume (30 Days)
- WELL 2.7M
- GSK 5.3M
- Earning Date
- WELL 02-11-2025
- GSK 02-05-2025
- Dividend Yield
- WELL 1.80%
- GSK 4.21%
- EPS Growth
- WELL 139.07
- GSK N/A
- EPS
- WELL 1.57
- GSK 0.78
- Revenue
- WELL $7,991,118,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- WELL N/A
- GSK $7.57
- Revenue Next Year
- WELL $8.26
- GSK $5.22
- P/E Ratio
- WELL $94.87
- GSK $22.87
- Revenue Growth
- WELL 21.58
- GSK 3.46
- 52 Week Low
- WELL $87.87
- GSK $31.72
- 52 Week High
- WELL $152.81
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- WELL 67.18
- GSK 58.60
- Support Level
- WELL $140.80
- GSK $36.35
- Resistance Level
- WELL $152.81
- GSK $37.22
- Average True Range (ATR)
- WELL 3.10
- GSK 0.62
- MACD
- WELL 0.42
- GSK 0.04
- Stochastic Oscillator
- WELL 75.53
- GSK 65.58
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,137 in-place properties spread across the senior housing, medical office, and skilled nursing/post-acute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.